- You are here : Europe Home
-
Our Services
-
Merchant Banking
-
Nomura Phase4 Ventures
-
Investments
Investments
 | Acadia Pharmaceuticals (NASDAQ: ACAD) San Diego, US Small molecules for CNS disorders. |
 | Albireo Gothenburg, Sweden Small molecules for gastrointestinal diseases (AstraZeneca spin out). |
 | Altus Pharmaceuticals (NASDAQ: ALTU) Boston, US Protein therapeutics for metabolic diseases (Vertex spin-out). |
 | Arakis (acquired by Sosei, TSE4565) Oxford, UK Reprofiled molecules for inflammatory and respiratory diseases. |
 | Ark Therapeutics (LSE: AKT) London, UK Gene therapy for oncology and haematology. |
 | ARYx Therapeutics (NASDAQ: ARYX) San Francisco, US Safer drugs through retrometabolic engineering. |
 | Atani Tokyo, Japan Developing western drugs for the Japanese market. |
 | Avant Immunotherapeutics (NASDAQ: AVAN) Boston, US Small molecules for the manipulation of the immune system. |
 | Cerimon Pharmaceuticals San Francisco, US Therapies for pain, autoimmune and inflammatory disease. |
 | Chroma Therapeutics Oxford, UK Small molecules for oncology and inflammation. |
 | Contec Medical Israel Medical imaging device for diagnosis and surgery. |
 | DeveloGen Goettingen, Germany Peptides and small molecules for metabolic diseases. |
 | DrugAbuse Sciences (acquired by Elbion) Paris, France Small molecules for the treatment of addictions. |
 | Idenix (NASDAQ: IDIX) Boston, US Small molecules for Hepatitis B and C. |
 | Immgenics (acquired by Abgenix - now Amgen NASDAQ: AMGN) Vancouver, Canada Antibody selection technology. |
 | Intercell (VSE: ICLL) Vienna, Austria Vaccines for bacterial and viral infections. |
 | Morphochem (acquired by Biovertis) Munich, Germany Small molecule anti-infectives and anti-coagulants. |
 | Nabriva Therapeutics Vienna, Austria Small molecules for bacterial infections (Sandoz spin-out). |
 | OmniSonics Medical Technologies Boston, US Device for clearance of occluded blood vessels. |
 | OncoMed Pharmaceuticals San Francisco, US Developing antibodies to cancer stem cells. |
 | Paratek Pharmaceuticals Boston, US Small molecules for bacterial infections. |
 | Pharmion (acquired by Celgene, NASDAQ: CELG) Boulder, US Small molecules for oncology and haematology. |
 | Phenomix San Diego, US Small molecules for Type 2 diabetes and Hepatitis C. |
 | Proteolix San Francisco, US Therapies targeting the proteasome to treat oncology and autoimmune diseases. |
 | Sequenom (NASDAQ: SQNM) San Diego, US Diagnostics for rapid genetic analysis. |
 | Targacept (NASDAQ: TRGT) Winston-Salem, US Small molecules for CNS conditions. |
 | Viacell (acquired by PerkinElmer, NYSE: PKI) Boston, US Cord blood banking and cell therapies. |
 | Weston Medical Stradbroke, UK Needle free drug delivery. |
 | Zosano Pharma (formerly The Macroflux Corporation) San Francisco, US Transdermal drug delivery technology (Alza/J&J spin-out). |
- For more information please contact the Nomura Phase4 Ventures team
